Ware, United Kingdom

Jacqueline Anne Carr


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacqueline Anne Carr: Innovator in Infectious Disease Treatment

Introduction

Jacqueline Anne Carr is a notable inventor based in Ware, GB. She has made significant contributions to the field of medicine, particularly in the treatment of infectious diseases. Her innovative approach combines various therapeutic agents to enhance treatment efficacy.

Latest Patents

Jacqueline holds 1 patent for her invention titled "Use of IL-12 and IFN.alpha. for the treatment of infectious diseases." This invention provides a combination of IL-12 and IFN.alpha. along with a pharmaceutically acceptable carrier. It is designed for the treatment and prophylaxis of infectious diseases, especially chronic infections such as viral infections like HSV, HIV, Hepatitis B, and Hepatitis C. Additionally, it addresses bacterial infections, including tuberculosis and salmonellosis, as well as parasitic infections like malaria and leishmaniasis. The compositions are characterized by the synergistic interaction of IL-12 and IFN.alpha., which enhances their therapeutic potential.

Career Highlights

Jacqueline is currently associated with Hoffmann-La Roche Inc., where she continues to work on innovative solutions for infectious diseases. Her research and development efforts have positioned her as a key figure in her field.

Collaborations

Jacqueline has collaborated with esteemed colleagues such as Gottfried Alber and Frank Albert Mattner. These partnerships have further enriched her research and contributed to advancements in medical treatments.

Conclusion

Jacqueline Anne Carr's work exemplifies the impact of innovation in the medical field, particularly in combating infectious diseases. Her contributions are vital for improving treatment options and enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…